Measuring pharmacogenetics in special groups: geriatrics

Bibliography

• Franceschi M, Scarcelli C, Niro V, et al. Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients. Drug Saf 2008;31:545–56
   PubMed Web of Science ®Google Scholar
• Petrovic M, van der Cammen T, Onder G. Adverse drug reactions in older people: detection and prevention. Drugs Aging 2012;29:453–62
   PubMed Web of Science ®Google Scholar
• Moore TJ, Cohen MR, Furberg CD. Serious adverse drug events reported to the Food and Drug Administration, 1998–2005. Arch Intern Med 2007;167:1752–9
   PubMed Web of Science ®Google Scholar
• Miguel A, Azevedo LF, Araújo M, et al. Frequency of adverse drug reactions in hospitalized patients: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf 2012;21:1139–54
   PubMed Web of Science ®Google Scholar
• AHRQ - Agency for Healthcare Research and Quality, Advancing Excellence in Health Care. Reducing and preventing adverse drug events to decrease hospital costs. Research in action Available from: http://archive.ahrq.gov/research/findings/factsheets/errors-safety/aderia/ade.html
   Google Scholar
• Marcum ZA, Pugh MJ, Amuan ME, et al. Prevalence of potentially preventable unplanned hospitalizations caused by therapeutic failures and adverse drug withdrawal events among older veterans. J Gerontol A Biol Sci Med Sci 2012;67:867–74
   PubMed Web of Science ®Google Scholar
• Patel RS, Marcum ZA, Peron EP, et al. Prevalence of and factors associated with therapeutic failure-related hospitalizations in the elderly. Consult Pharm 2014;29:376–86
   PubMedGoogle Scholar
• Motulsky AG. Drug reactions, enzymes, and biochemical genetics. J Am Med Assoc 1957;165:835–7
   PubMed Web of Science ®Google Scholar
• Vogel F. Moderne Probleme der Humangenetik. Ergeb Inn Med Kinderheilkd 1959;12:52–125
   Google Scholar
• Meyer UA. Pharmacogenetics and adverse drug reactions. Lancet 2000;356:1667–71
   PubMed Web of Science ®Google Scholar
• Pirmohamed M, Park BK. Genetic susceptibility to adverse drug reactions. Trends Pharmacol Sci 2001;22:298–305
   PubMed Web of Science ®Google Scholar
• Güzey C, Spigset O. Genotyping as a tool to predict adverse drug reactions. Curr Top Med Chem 2004;4:1411–21
   PubMed Web of Science ®Google Scholar
• Wilke RA, Lin DW, Roden DM, et al. Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. Nat Rev Drug Discov 2007;6:904–16
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M. Pharmacogenomic biomarkers for prediction of severe adverse drug reactions. N Engl J Med 2008;358:637–9
   PubMed Web of Science ®Google Scholar
• Lynch T, Price A. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am Fam Physician 2007;76:391–6
   PubMed Web of Science ®Google Scholar
• Seripa D, Pilotto A, Panza F, et al. Pharmacogenetics of cytochrome P450 (CYP) in the elderly. Ageing Res Rev 2010;9:457–74
   PubMed Web of Science ®Google Scholar
• Johansson I, Ingelman-Sundberg M. Genetic polymorphism and toxicology - with emphasis on cytochrome p450. Toxicol Sci 2011;120:1–13
   PubMed Web of Science ®Google Scholar
• Schuler MA. The role of cytochrome P450 monooxygenases in plant-insect interactions. Plant Physiol 1996;112:1411–19
   PubMed Web of Science ®Google Scholar
• Gonzalez FJ, Nebert DW. Evolution of the P450 gene superfamily: animal–plant ‘warfare’, molecular drive and human genetic differences in drug oxidation. Trends Genet 1990;6:182–6
   PubMed Web of Science ®Google Scholar
• Nelson DR. Metazoan cytochrome P450 evolution. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1998;121:15–22
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M, Oscarson M, McLellan RA. Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment. Trends Pharmacol Sci 1999;20:342–9
   PubMed Web of Science ®Google Scholar
• Pilotto A, Panza F, Seripa D. Pharmacogenetics in geriatric medicine: challenges and opportunities for clinical practice. Curr Drug Metab 2011;12(7):621–34
   PubMed Web of Science ®Google Scholar
• Seripa D, Paroni G, Urbano M, et al. Pharmacogenetics in older people: what we know and what we need to know. J Nephrol 2012;25(Suppl 19):S38–47
   PubMed Web of Science ®Google Scholar
• Thomas JH. Rapid birth-death evolution specific to xenobiotic cytochrome P450 genes in vertebrates. PLoS Genet 2007;3:e67
   PubMed Web of Science ®Google Scholar
• Rendic S. Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev 2002;34:83–448
   PubMed Web of Science ®Google Scholar
• Molecular basis of disease. Cytochrome P450s in humans. Available from: http://drnelson.uthsc.edu/P450.talks.html
   Google Scholar
• Sim SC, Ingelman-Sundberg M. The human cytochrome P450 Allele Nomenclature Committee Web site: submission criteria, procedures, and objectives. Methods Mol Biol 2006;320:183–91
   PubMedGoogle Scholar
• The Human Cytochrome P450 (CYP) Allele Nomenclature Database. Allele nomenclature for Cytochrome P450 enzymes. Available from: http://www.cypalleles.ki.se/
   Google Scholar
• Daly AK, Cholerton S, Gregory W, Idle JR. Metabolic polymorphisms. Pharmacol Ther 1993;57:129–60
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M, Oscarson M, McLellan RA. Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment. Trends Pharmacol Sci 1999;20:342–9
   PubMed Web of Science ®Google Scholar
• Evans WE, Relling MV. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 1999;286:487–91
   PubMed Web of Science ®Google Scholar
• Gardiner SJ, Begg EJ. Pharmacogenetics, drug-metabolizing enzymes, and clinical practice. Pharmacol Rev 2006;58:521–90
   PubMed Web of Science ®Google Scholar
• Preissner SC, Hoffmann MF, Preissner R, et al. Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy. PLoS ONE 2013;8:e82562
   PubMed Web of Science ®Google Scholar
• Caraco Y. Genes and the response to drugs. N Engl J Med 2004;351:2867–9
   PubMed Web of Science ®Google Scholar
• de Leon J, Arranz MJ, Ruaño G. Pharmacogenetic testing in psychiatry: a review of features and clinical realities. Clin Lab Med 2008;28:599–617
   PubMed Web of Science ®Google Scholar
• Crick F. Central dogma of molecular biology. Nature 1970;227:561–3
   PubMed Web of Science ®Google Scholar
• Petronis A, Gottesman II, Kan P, et al. Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance? Schizophr Bull 2003;29:169–78
   PubMed Web of Science ®Google Scholar
• Fraga MF, Ballestar E, Paz MF, et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 2005;102:10604–9
   PubMed Web of Science ®Google Scholar
• Baer-Dubowska W, Majchrzak-Celinska M, Cichocki M. Pharmacoepigenetics: a new approach to predicting individual drug responses and targeting new drugs. Pharmacol Rep 2011;63:293–304
   PubMed Web of Science ®Google Scholar
• Kacevska M, Ivanov M, Ingelman-Sundberg M. Perspectives on epigenetics and its relevance to adverse drug reactions. Clin Pharmacol Ther 2011;89:902–7
   PubMed Web of Science ®Google Scholar
• Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A. An operational definition of epigenetics. Genes Dev 2009;23:781–3
   PubMed Web of Science ®Google Scholar
• Mukherjee K, Twyman RM, Vilcinskas A. Insects as models to study the epigenetic basis of disease. Prog Biophys Mol Biol 2015;10.1016/j.pbiomolbio.2015.02.009
   PubMed Web of Science ®Google Scholar
• Steves CJ, Spector TD, Jackson SH. Ageing, genes, environment and epigenetics: what twin studies tell us now, and in the future. Age Ageing 2012;41:581–6
   PubMed Web of Science ®Google Scholar
• Casadesús J, Low D. Epigenetic gene regulation in the bacterial world. Microbiol Mol Biol Rev 2006;70:830–56
   PubMed Web of Science ®Google Scholar
• Zemach A, McDaniel IE, Silva P, et al. Genome-wide evolutionary analysis of eukaryotic DNA methylation. Science 2010;328:916–19
   PubMed Web of Science ®Google Scholar
• Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006;31:89–97
   PubMed Web of Science ®Google Scholar
• Reddington JP, Pennings S, Meehan RR. Non-canonical functions of the DNA methylome in gene regulation. Biochem J 2013;451:13–23
   PubMed Web of Science ®Google Scholar
• Okano M, Xie S, Li E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet 1998;19:219–20
   PubMed Web of Science ®Google Scholar
• Xie S, Wang Z, Okano M, et al. Cloning, expression and chromosome locations of the human DNMT3 gene family. Gene 1999;236:87–95
   PubMed Web of Science ®Google Scholar
• Hermann A, Gowher H, Jeltsch A. Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol Life Sci 2004;61:2571–87
   PubMed Web of Science ®Google Scholar
• Christensen BC, Houseman EA, Marsit CJ, et al. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet 2009;5:e1000602
   PubMed Web of Science ®Google Scholar
• Shoemaker R, Deng J, Wang W, et al. Allele-specific methylation is prevalent and is contributed by CpG-SNPs in the human genome. Genome Res 2010;20:883–9
   PubMed Web of Science ®Google Scholar
• Kerkel K, Spadola A, Yuan E, et al. Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation. Nat Genet 2008;40:904–8
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M, Sim SC, Gomez A, et al. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol Ther 2007;116:496–526
   PubMed Web of Science ®Google Scholar
• Hirota T, Takane H, Higuchi S, et al. Epigenetic regulation of genes encoding drug-metabolizing enzymes and transporters; DNA methylation and other mechanisms. Curr Drug Metab 2008;9:34–8
   PubMed Web of Science ®Google Scholar
• Gomez A, Ingelman-Sundberg M. Pharmacoepigenetics: its role in interindividual differences in drug response. Clin Pharmacol Ther 2009;85:426–30
   PubMed Web of Science ®Google Scholar
• Gomez A, Ingelman-Sundberg M. Epigenetic and microRNA-dependent control of cytochrome P450 expression: a gap between DNA and protein. Pharmacogenomics 2009;10:1067–76
   PubMed Web of Science ®Google Scholar
• Tang J, Xiong Y, Zhou HH, et al. DNA methylation and personalized medicine. J Clin Pharm Ther 2014;39:621–7
   PubMed Web of Science ®Google Scholar
• Zanger UM, Klein K, Thomas M, et al. Genetics, epigenetics, and regulation of drug-metabolizing cytochrome p450 enzymes. Clin Pharmacol Ther 2014;95:258–61
   PubMed Web of Science ®Google Scholar
• Naselli F, Catanzaro I, Bellavia D, et al. Role and importance of polymorphisms with respect to DNA methylation for the expression of CYP2E1 enzyme. Gene 2014;536:29–39
   PubMed Web of Science ®Google Scholar
• Rodriguez-Antona C, Gomez A, Karlgren M, et al. Molecular genetics and epigenetics of cytochrome P450 gene family and its relevance for cancer risk and treatment. Hum Genet 2010;127:1–17
   PubMed Web of Science ®Google Scholar
• Nakajima M, Iwanari M, Yokoi T. Effects of histone deacetylation and DNA methylation on the constitutive and TCDD-inducible expressions of the human CYP1 family in MCF-7 and HeLa cells. Toxicol Lett 2003;144:247–56
   PubMed Web of Science ®Google Scholar
• Okino ST, Pookot D, Li LC, et al. Epigenetic inactivation of the dioxin-responsive cytochrome P4501A1 gene in human prostate cancer. Cancer Res 2006;66:7420–8
   PubMed Web of Science ®Google Scholar
• Anttila S, Hakkola J, Tuominen P, et al. Methylation of cytochrome P4501A1 promoter in the lung is associated with tobacco smoking. Cancer Res 2003;63:8623–8
   PubMed Web of Science ®Google Scholar
• Hammons GJ, Yan-Sanders Y, Jin B, et al. Specific site methylation in the 5′-flanking region of CYP1A2 interindividual differences in human livers. Life Sci 2001;69:839–45
   PubMed Web of Science ®Google Scholar
• Ghotbi R, Gomez A, Milani L, et al. Allele-specific expression and gene methylation in the control of CYP1A2 mRNA level in human livers. Pharmacogenomics J 2009;9:208–17
   PubMed Web of Science ®Google Scholar
• Tokizane T, Shiina H, Igawa M, et al. Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin Cancer Res 2005;11:5793–801
   PubMed Web of Science ®Google Scholar
• Habano W, Gamo T, Sugai T, et al. CYP1B1, but not CYP1A1, is downregulated by promoter methylation in colorectal cancers. Int J Oncol 2009;34:1085–91
   PubMed Web of Science ®Google Scholar
• Kerkel K, Spadola A, Yuan E, et al. Genomic surveys by methylation-sensitive SNP analysis-identify sequence-dependent-allele-specific DNA methylation. Nat Genet 2008;40:904–8
   PubMed Web of Science ®Google Scholar
• Jones SM, Boobis AR, Moore GE, et al. Expression of CYP2E1 during human fetal development: methylation of the CYP2E1 gene in human fetal and adult liver samples. Biochem Pharmacol 1992;43:1876–9
   PubMed Web of Science ®Google Scholar
• Oneta CM, Lieber CS, Li J, et al. Dynamics of cytochrome P4502E1 activity in man: induction by ethanol, and disappearance during withdrawal phase. J Hepatol 2002;36:47–52
   PubMed Web of Science ®Google Scholar
• Dannenberg LO, Edenberg HJ. Epigenetics of gene expression in human hepatoma cells: expression profiling the response to inhibition of DNA methylation and histone deacetylation. BMC Genomics 2006;7:181
   PubMed Web of Science ®Google Scholar
• Kacevska M, Ivanov M, Wyss A, et al.A methylation dynamics in the hepatic CYP3A4 gene promoter. Biochimie 2012;94:2338–44
   PubMed Web of Science ®Google Scholar
• Novakovic B, Sibson M, Ng HK, et al. Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface. J Biol Chem 2009;284:14838–48
   PubMed Web of Science ®Google Scholar
• Johnson CS, Chung I, Trump DL. Epigenetic silencing of CYP24 in the tumor microenvironment. J Steroid Biochem Mol Biol 2010;121:338–42
   PubMed Web of Science ®Google Scholar
• Penaloza CG, Estevez B, Han DM, et al. Sex-dependent regulation of cytochrome P450 family members CYP1A1, CYP2E1, and CYP7B1 by methylation of DNA. FASEB J 2014;28:966–77
   PubMed Web of Science ®Google Scholar
• Cosentino C, Mostoslavsky R. Metabolism, longevity and epigenetics. Cell Mol Life Sci 2013;70:1525–41
   PubMed Web of Science ®Google Scholar
• Boyd-Kirkup JD, Green CD, Wu G, et al. Epigenomics and the regulation of aging. Epigenomics 2013;5:205–27
   PubMed Web of Science ®Google Scholar
• Brunet A, Berger SL. Epigenetics of aging and aging-related disease. J Gerontol A Biol Sci Med Sci 2014;69:17–20
   PubMed Web of Science ®Google Scholar
• Issa JP. Aging and epigenetic drift: a vicious cycle. J Clin Invest 2014;124:24–9
   PubMed Web of Science ®Google Scholar
• Johnson AA, Akman K, Calimport SR, et al. The role of DNA methylation in aging, rejuvenation, and age-related disease. Rejuvenation Res 2012;15:483–94
   PubMed Web of Science ®Google Scholar
• Ben-Avraham D, Muzumdar RH, Atzmon G. Epigenetic genome-wide association methylation in aging and longevity. Epigenomics 2012;4:503–9
   PubMed Web of Science ®Google Scholar
• Li Y, Liu Y, Strickland FM, et al. Age-dependent decreases in DNA methyltransferase levels and low transmethylation micronutrient levels synergize to promote overexpression of genes implicated in autoimmunity and acute coronary syndromes. Exp Gerontol 2010;45:312–22
   PubMed Web of Science ®Google Scholar
• Oliveira AM, Hemstedt TJ, Bading H. Rescue of aging-associated decline in DNMT3a2 expression restores cognitive abilities. Nat Neurosci 2012;15:1111–13
   PubMed Web of Science ®Google Scholar
• Guo JU, Ma DK, Mo H, et al. Neuronal activity modifies the DNA methylation landscape in the adult brain. Nat Neurosci 2011;14:1345–51
   PubMed Web of Science ®Google Scholar
• Talens RP, Christensen K, Putter H, et al. Epigenetic variation during the adult lifespan: cross-sectional and longitudinal data on monozygotic twin pairs. Aging Cell 2012;11:694–703
   PubMed Web of Science ®Google Scholar
• Hernandez DG, Nalls MA, Gibbs JR, et al. Distinct DNA methylation changes highly correlated with chronological age in the human brain. Hum Mol Genet 2011;20:1164–72
   PubMed Web of Science ®Google Scholar
• Martin GM. Epigenetic drift in aging identical twins. Proc Natl Acad Sci USA 2005;102:10413–14
   PubMed Web of Science ®Google Scholar
• Grönniger E, Weber B, Heil O, et al. Aging and chronic sun exposure cause distinct epigenetic changes in human skin. PLoS Genet 2010;6:e1000971
   PubMedGoogle Scholar
• Rakyan VK, Down TA, Maslau S, et al. Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains. Genome Res 2010;20:434–9
   PubMed Web of Science ®Google Scholar
• Bjornsson HT, Sigurdsson MI, Fallin MD, et al. Intra-individual change over time in DNA methylation with familial clustering. JAMA 2008;299:2877–83
   PubMed Web of Science ®Google Scholar
• Bollati V, Schwartz J, Wright R, et al. Decline in genomic DNA methylation through aging in a cohort of elderly subjects. Mech Ageing Dev 2009;130:234–9
   PubMed Web of Science ®Google Scholar
• Liu L, van Groen T, Kadish I, et al. Insufficient DNA methylation affects healthy aging and promotes age-related health problems. Clin Epigenet 2011;2:349–60
   PubMed Web of Science ®Google Scholar
• Heyn H, Li N, Ferreira HJ, et al. Distinct DNA methylomes of newborns and centenarians. Proc Natl Acad Sci USA 2012;109:10522–7
   PubMed Web of Science ®Google Scholar
• Casillas MAJr, Lopatina N, Andrews LG, et al. Transcriptional control of the DNA methyltransferases is altered in aging and neoplastically-transformed human fibroblasts. Mol Cell Biochem 2003;252:33–43
   PubMed Web of Science ®Google Scholar
• Kwak HC, Kim HC, Oh SJ, Kim SK. Effects of age increase on hepatic expression and activity of cytochrome P450 in male C57BL/6 mice. Arch Pharm Res 2014;doi:10.1007/s12272-014-0452-z
   Web of Science ®Google Scholar
• Feser J, Tyler J. Chromatin structure as a mediator of aging. FEBS Lett 2011;585:2041–8
   PubMed Web of Science ®Google Scholar
• O’Sullivan RJ, Karlseder J. The great unravelling: chromatin as a modulator of the aging process. Trends Biochem Sci 2012;37:466–47
   PubMed Web of Science ®Google Scholar
• Liu L, Cheung TH, Charville GW, et al. Chromatin modifications as determinants of muscle stem cell quiescence and chronological aging. Cell Rep 2013;4:189–204
   PubMed Web of Science ®Google Scholar
• Maures TJ, Greer EL, Hauswirth AG, et al. The H3K27 demethylase UTX-1 regulates C.elegans lifespan in a germline-independent, insulin-dependent manner. Aging Cell 2011;10:980–90
   PubMed Web of Science ®Google Scholar
• Wood JG, Hillenmeyer S, Lawrence C, et al. Chromatin remodeling in the aging genome of Drosophila. Aging Cell 2010;9:971–8
   PubMed Web of Science ®Google Scholar
• Price BD, D’Andrea AD. Chromatin remodeling at DNA double-strand breaks. Cell 2013;152:1344–54
   PubMed Web of Science ®Google Scholar
• McCauley BS, Dang W. Histone methylation and aging: lessons learned from model systems. Biochim Biophys Acta 2014;1839:1454–62
   PubMed Web of Science ®Google Scholar
• Harries LW. MicroRNAs as mediators of the ageing process. Genes (Basel) 2014;5:656–70
   PubMed Web of Science ®Google Scholar
• Jung HJ, Suh Y. Circulating miRNAs in ageing and ageing-related diseases. J Genet Genomics 2014;41:465–72
   PubMed Web of Science ®Google Scholar
• Kacevska M, Ivanov M, Ingelman-Sundberg M. Epigenetic-dependent regulation of drug transport and metabolism: an update. Pharmacogenomics 2012;13:1373–85
   PubMed Web of Science ®Google Scholar
• Fontana L, Partridge L, Longo VD. Extending healthy life span--from yeast to humans. Science 2010;328:321–6
   PubMed Web of Science ®Google Scholar
• Omodei D, Fontana L. Calorie restriction and prevention of age-associated chronic disease. FEBS Lett 2011;585:1537–42
   PubMed Web of Science ®Google Scholar
• Fontana L, Kennedy BK, Longo VD, et al. Medical research: treat ageing. Nature 2014;511:405–7
   PubMed Web of Science ®Google Scholar
• Kelkar SS, Reineke TM. Theranostics: combining imaging and therapy. Bioconjug Chem 2011;22:1879–903
   PubMed Web of Science ®Google Scholar
• Jeelani S, Reddy RC, Maheswaran T, et al. Theranostics: A treasured tailor for tomorrow. J Pharm Bioallied Sci 2014;6(Suppl 1):S6–8
   PubMedGoogle Scholar
• Bartlett G, Antoun J, Zgheib NK. Theranostics in primary care: pharmacogenomics tests and beyond. Expert Rev Mol Diagn 2012;12:841–55
   PubMed Web of Science ®Google Scholar